Cajal-like interstitial cells as a novel target in detrusor overactivity treatment: true or myth?
BACKGROUND
The Cajal-like intestitial cells (ICCs) act as a pacemaker and are responsible for generating smooth muscle activity in the gastrointestinal tract (GI). Interstitial cells that resemble ICCs in the GI have been identified in the urinary bladder.


METHODS
This review is based on a systemic literature research. The medline/pubmed, scopus, embase, and Web of Science databases were browsed in order to identify original and review articles, as well as editorials relating to cajal-like cells, urinary bladder, detrusor overactivity, overactive bladder, glivec, etc. The controlled vocabulary of the Medical Subject Headings (MeSH) database was used to ensure the sensitivity of the searches. 40 papers met the criteria and were used for this review.


RESULTS
Cajal cells lie in close proximity to the muscle cells, autonomic nerve endings, and urothelial cells. There is increasing evidence that ICCs play role in urinary tract dysfunction development (e.g. detrusor overactivity, primary obstructive megaureter, congenital ureteropelvic junction obstruction, etc.). ICCs may be responsible for generating electrical potentials and induction of detrusor muscle contractions. Novel pathomechanisms of detrusor overactivity development have been postulated, as follows: 1) the disturbance of spontaneous contractility caused by altered signal transduction of ICCs between nerves and detrusor muscle cells, and 2). the alteration in signal transduction between urothelium and afferent nerve endings via suburothelial ICCs. The c-kit receptor is not only a detection marker of these cells, but may also play a crucial role in the control of bladder function.


CONCLUSIONS
Cajal cells in urinary bladder suggest that the c-kit receptor may provide a novel target for treating detrusor overactivity. The review presents the current knowledge of ICCs, its role in urinary bladder function, and potential novel therapeutic strategy.
Department of Pathophysiology, Jagiellonian University, Medical College, Cracow, Poland ; Department of Urology, Memorial Rydygier Hospital, Cracow, Poland.
Kajetan
K
Juszczak
Department of Urology, Memorial Rydygier Hospital, Cracow, Poland.
Piotr
P
Maciukiewicz
Department of Tissue Engineering, Medical College, Nicolaus Copernicus University, Toruń, Poland ; Department of Urology, Nicolaus Copernicus University, Toruń, Poland.
Tomasz
T
Drewa
Department of Pathophysiology, Jagiellonian University, Medical College, Cracow, Poland.
Piotr J
PJ
Thor
cajal cells; glivec; overactive bladder; treatment